The two organizations will launch clinical trials using AI to explore how the technology can be used for cardiovascular disease research, as well as how it can prevent bias, according to an Oct. 5 news release from Mount Sinai.
Chiba researchers, who are located in Japan, will fly to Mount Sinai to learn more about cardiovascular care used by the health system, and Mount Sinai researchers will visit Japan to explore the technological advancements of Chiba.
The aim of the collaboration is to identify new treatments for patients with cardiovascular disease, as well as gain greater knowledge on how to better prevent the disease.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
